Supernus Pharmaceuticals | 8-K: Current report
Apr 24 16:11 ET
Supernus Pharmaceuticals | 8-K: Current report
Apr 24 16:10 ET
Supernus Pharmaceuticals | 8-K: Current report
Apr 8 08:07 ET
Supernus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Bhatt Padmanabh P.
Mar 25 17:04 ET
Supernus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Bhatt Padmanabh P.
Mar 22 17:04 ET
Supernus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Bhatt Padmanabh P.
Mar 21 17:07 ET
Supernus Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Mar 19 16:26 ET
Supernus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Bhatt Padmanabh P.
Mar 15 18:42 ET
Supernus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Bhatt Padmanabh P.
Mar 14 17:05 ET
Supernus Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Mar 13 16:25 ET
Supernus Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Mar 12 16:30 ET
Supernus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Khattar Jack A.
Feb 29 17:05 ET
Supernus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Mottola Frank
Feb 29 17:04 ET
Supernus Pharmaceuticals | 8-K: Current report
Feb 28 17:15 ET
Supernus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Bhatt Padmanabh P.
Feb 28 17:15 ET
Supernus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director GEMAYEL GEORGES
Feb 27 22:46 ET
Supernus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director SIEBERT JOHN M
Feb 27 17:10 ET
Supernus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Hudson Frederick M.
Feb 27 17:10 ET
Supernus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Barlow Carrolee
Feb 27 17:09 ET
Supernus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director NEWHALL CHARLES W III
Feb 27 17:09 ET
No Data
No Data